Taurine manufacturer Yongan Pharmaceutical predicts large rise in H1 2016 net profit

Summary: Yongan Pharmaceutical announced a large rise in its H1 2016 net profit, mainly due to the growth of both the sales volume and price of its taurine products. The leading taurine manufacturer may continue to raise prices in order to boost prof...

More from CCM

www.cnchemicals.com